| ZScore | RScore | Entity Type | ID | Name | Synonyms |
|---|---|---|---|---|---|
| 1.0889847218 | 35 - [0, 0, 1, 2] | Diseases | DID69824 | Autism spectrum disorder | Autism spectrum disorder |
| RScore | Document | Snippets | Details |
|---|---|---|---|
| 30 - [0, 0, 1, 1] |
Sex Differences in the Effects of Prenatal Bisphenol A Exposure on Genes Associated with Autism Spectrum Disorder in the Hippocampus. [MEDLINE : 30816183] |
(2019) Sex Differences in the Effects of Prenatal Bisphenol A Exposure on Genes Associated with Autism Spectrum Disorder in the Hippocampus. Scientific reports;Sci Rep;2019 Feb;9(1):3038 - Sex Differences in the Effects of Prenatal Bisphenol A Exposure on Genes Associated with Autism Spectrum Disorder in the Hippocampus. - Autism spectrum disorder (ASD) is a neurodevelopmental disorder inexplicably biased towards males. |
Details |
| 5 - [0, 0, 0, 1] |
Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases. [MEDLINE : 27983596] |
(2016) Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases. International journal of molecular sciences;Int J Mol Sci;2016 Dec;17(12): - Some of these genes are involved with brain diseases, such as Alzheimer 's Disease (AD), Parkinson 's Disease, Huntington 's Disease, Amyotrophic Lateral Sclerosis, Autism Spectrum Disorder, and Brain Neoplasms. |
Details |
Liu Y., Liang Y., Wishart D.S. (2015) PolySearch 2.0: A significantly improved text-mining system for discovering associations between human diseases, genes, drugs, metabolites, toxins, and more. Nucleic Acids Res. 2015 Jul 1;43(Web Server Issue):W535-42.
Cheng D., Knox C., Young N., Stothard P., Damaraju S., Wishart D.S. (2008) PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res. 2008 Jul 1;36(Web Server Issue):W399-405.
This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $900 million in funding from the federal government.